Development of Oral Azacitidine with Cedazuridine for Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) Including CMML (chronic Myelomonocytic Leukemia) by Targeting Pharmacokinetic AUC Equivalence Vs Subcutaneous Azacitidine

Clinical Lymphoma Myeloma & Leukemia(2024)

引用 0|浏览0
暂无评分
关键词
Acute Myeloid Leukemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要